|Articles|November 9, 2010

Early Employer-Based Flu Vaccinations Can Protect Health and Improve Company's Bottom Line

Each year, influenza poses a tremendous burden on working adults and the many businesses that employ them, contributing to absenteeism and lost productivity. Yet, annual influenza immunization rates remain very low. New data out today show that employer-sponsored influenza vaccination programs held early in the flu season not only protect employee health, but save businesses money.

 

Researchers from the University of Pittsburgh, who presented the findings at the American Public Health Associations 138th annual meeting and exposition in Denver, developed an economic model to suggest that not only should employers get their employees vaccinated, they should do so as early as possible.

 

Using historic influenza data from the Centers for Disease Control and Prevention and wage data from the U.S. Department of Labor, the models show that getting an employee immunized in November instead of December can save an employer between $63 and $95 per person. Vaccinating an entire firm of 150 employees earlier could save a business between $9,450 and $14,250. The potential cost savings of influenza immunization drop dramatically for vaccination after December.

 

Employers have huge incentives to solve this widespread public health problem with timely vaccination, says Rachel Bailey, MPH, lead researcher of the study. Even though sponsoring workplace vaccination may appear expensive, the cost savings provided by preventing influenza-associated absenteeism with vaccination programs early in the influenza season more than compensates.

The researchers involved in this study are Rachel Bailey, MPH, Julie H.Y. Tai, MD, Ann E. Wiringa, MPH, Abena Afriyie, Angela R. Wateska, MPH, Kenneth J. Smith, MD, MS, Richard K. Zimmerman, MD, MPH, and Bruce Y. Lee, MD, MBA.


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERISS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.